Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs

CNBC December 9, 2025
Annika Kim Constantino

Key Points

– Eli Lilly said it will spend $6 billion to build a manufacturing plant in Huntsville, Alabama, to help boost production of its closely watched experimental obesity pill, orforglipron, and other drugs.

– It is the third facility in a string of new planned U.S. investments by the drugmaker.

– That added production capacity for Eli Lilly’s obesity pill, orforglipron, is crucial as the company races to file for its approval and tries to maintain its dominance in the booming market for GLP-1s.

Eli Lilly on Tuesday said it will spend $6 billion to build a manufacturing plant in Huntsville, Alabama, to help boost production of its closely watched experimental obesity pill and other drugs.

It...

Today's Sponsors

Today's Sponsor